GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
R

Rossmax International 4121.TWO · TWD

Health Care · Taipei Exchange · 🇹🇼 Taiwan

Compare

12.10

+1.26%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Rossmax International

Its shares trade on Taipei Exchange under the ticker 4121.TWO. It has been listed since 28 November 2002. In the fiscal year to 31 December 2025, it reported revenue of TWD 3.80bn and a net loss of TWD 29.9m. At that date it held total assets of TWD 4.21bn and shareholders' equity of TWD 1.41bn.

Rossmax International Ltd. engages in the design, sale, manufacture, research and development of healthcare products. The company is headquartered in Taipei City, Taipei. The company went IPO on 2002-11-28. The firm's main products include digital sphygmomanometers, respiratory therapy products, temperature series products and blood oxygen meters. The firm distributes its products in domestic market and to overseas markets, including Europe, the Americas and others.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Equipment & Supplies
Listed since
28 Nov 2002
Employees
965
Website
rossmax.com ↗

Leadership

Pay as last reported

  • Mr. Zhiping LiuChairman of the Board, General Manager, since 1988
  • Ms. Shujuan ZhangChief Financial Officer, Deputy General Manager-Finance Division, since 2019
  • Lixian ChenDeputy General Manager-Administration Management, since 2018
  • Zhirong ChenDeputy General Manager-Deputy General Manager's Office, since 2002
  • Yuqiao QiDeputy General Manager-R&D and Quality Management Division
  • Morten BrunvollDirector
  • Mr. Li-Hen HuangDirector
  • Zonghan LiDirector
  • Zhizhong WuDirector
  • Qingwei ZhangDirector
  • Yixun ChenIndependent Director
  • Yanping JiIndependent Director, since 2023

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Headquartered in Taipei City, Taipei
  • Offers a range of healthcare products including digital sphygmomanometers and blood oxygen meters
  • Distributes products domestically and internationally to Europe, the Americas, and other markets

Weaknesses

  • No specific weaknesses mentioned in the provided information
  • No details on financial performance or market share provided
  • No information on competitive advantages or unique selling points

Opportunities

  • Potential growth in global healthcare product markets
  • Expansion into new international markets beyond current distribution areas
  • Increasing demand for healthcare monitoring devices

Threats

  • Competition from other healthcare product manufacturers
  • Economic downturns affecting healthcare spending
  • Regulatory changes in international markets

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.